'Iron Still Hot,' as FDA Vague on Off-Label Speech Freedom
By Randy Osborne
Thursday, January 31, 2013
Late last year, when federal appeals judges threw out the conviction of a former pharma sales rep for off-label marketing after the rep argued that prosecuting him had violated his freedom of speech, the industry could not be sure what it meant for the rest of them.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.